Form 8-K - Current report:
SEC Accession No. 0001104659-26-035238
Filing Date
2026-03-26
Accepted
2026-03-26 16:30:11
Documents
50
Period of Report
2026-03-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mtva-20260326x8k.htm   iXBRL 8-K 47729
2 EX-99.1 mtva-20260326xex99d1.htm EX-99.1 67021
3 GRAPHIC mtva-20260326x8k001.jpg GRAPHIC 9107
4 GRAPHIC mtva-20260326xex99d1g001.jpg GRAPHIC 45706
5 GRAPHIC mtva-20260326xex99d1g002.jpg GRAPHIC 195082
6 GRAPHIC mtva-20260326xex99d1g003.jpg GRAPHIC 126163
7 GRAPHIC mtva-20260326xex99d1g004.jpg GRAPHIC 154361
8 GRAPHIC mtva-20260326xex99d1g005.jpg GRAPHIC 154792
9 GRAPHIC mtva-20260326xex99d1g006.jpg GRAPHIC 94672
10 GRAPHIC mtva-20260326xex99d1g007.jpg GRAPHIC 30771
11 GRAPHIC mtva-20260326xex99d1g008.jpg GRAPHIC 144223
12 GRAPHIC mtva-20260326xex99d1g009.jpg GRAPHIC 205629
13 GRAPHIC mtva-20260326xex99d1g010.jpg GRAPHIC 213025
14 GRAPHIC mtva-20260326xex99d1g011.jpg GRAPHIC 164607
15 GRAPHIC mtva-20260326xex99d1g012.jpg GRAPHIC 150353
16 GRAPHIC mtva-20260326xex99d1g013.jpg GRAPHIC 49919
17 GRAPHIC mtva-20260326xex99d1g014.jpg GRAPHIC 146296
18 GRAPHIC mtva-20260326xex99d1g015.jpg GRAPHIC 114048
19 GRAPHIC mtva-20260326xex99d1g016.jpg GRAPHIC 153553
20 GRAPHIC mtva-20260326xex99d1g017.jpg GRAPHIC 145049
21 GRAPHIC mtva-20260326xex99d1g018.jpg GRAPHIC 25850
22 GRAPHIC mtva-20260326xex99d1g019.jpg GRAPHIC 180208
23 GRAPHIC mtva-20260326xex99d1g020.jpg GRAPHIC 154133
24 GRAPHIC mtva-20260326xex99d1g021.jpg GRAPHIC 131426
25 GRAPHIC mtva-20260326xex99d1g022.jpg GRAPHIC 41361
26 GRAPHIC mtva-20260326xex99d1g023.jpg GRAPHIC 18064
27 GRAPHIC mtva-20260326xex99d1g024.jpg GRAPHIC 30771
28 GRAPHIC mtva-20260326xex99d1g025.jpg GRAPHIC 120101
29 GRAPHIC mtva-20260326xex99d1g026.jpg GRAPHIC 76434
30 GRAPHIC mtva-20260326xex99d1g027.jpg GRAPHIC 120018
31 GRAPHIC mtva-20260326xex99d1g028.jpg GRAPHIC 137328
32 GRAPHIC mtva-20260326xex99d1g029.jpg GRAPHIC 121520
33 GRAPHIC mtva-20260326xex99d1g030.jpg GRAPHIC 125072
34 GRAPHIC mtva-20260326xex99d1g031.jpg GRAPHIC 49292
35 GRAPHIC mtva-20260326xex99d1g032.jpg GRAPHIC 120767
36 GRAPHIC mtva-20260326xex99d1g033.jpg GRAPHIC 118262
37 GRAPHIC mtva-20260326xex99d1g034.jpg GRAPHIC 149979
38 GRAPHIC mtva-20260326xex99d1g035.jpg GRAPHIC 153267
39 GRAPHIC mtva-20260326xex99d1g036.jpg GRAPHIC 105177
40 GRAPHIC mtva-20260326xex99d1g037.jpg GRAPHIC 146094
  Complete submission text file 0001104659-26-035238.txt   6248426

Data Files

Seq Description Document Type Size
41 EX-101.SCH mtva-20260326.xsd EX-101.SCH 2672
42 EX-101.LAB mtva-20260326_lab.xml EX-101.LAB 15926
43 EX-101.PRE mtva-20260326_pre.xml EX-101.PRE 10053
53 EXTRACTED XBRL INSTANCE DOCUMENT mtva-20260326x8k_htm.xml XML 4854
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
MetaVia Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 26798701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)